Abstract
A hyperdynamic state, characterized by an elevated blood pressure and tachycardia is frequently seen during the first few days following severe multiple trauma. We examined the cardiovascular effects of the alpha and beta adrenoceptor blocking agent labetalol in patients presenting a hyperdynamic cardiovascular state some days after major trauma. Ten patients with a heart rate-systolic blood pressure product (RPP) of more than 2000 during 6 consecutive hours, despite normovolaemia, adequate ventilation, analgesia and sedation were investigated. After a mean dose of 2.1±1.2 mg·kg-1 (mean±SD) of labetalol injected intravenously over a 10-min period, heart rate decreased from 117±28 to 102±19 beats·min-1, systolic arterial pressure from 25±3.5 to 18.5±2.7 kPa, diastolic pressure from 11±1.7 to 9.5±1.7 kPa, mean arterial blood pressure from 15.5±2.1 to 12.4±2.1 kPa, and the RPP from 2880±867 to 1853±373. The beneficial effect of this dose lasted 24 h in 8 of 10 patients without additional administration. No important side effects such as cardiac arrhythmias, hypotension, or bronchospasm were noted. We conclude that labetalol used in fractional intravenous doses permits an adequate treatment of a “hypertension-tachycardia syndrome” in severely injured patients.
Similar content being viewed by others
References
Agabiti-Rosei E, Alicandri CL, Beschi M, Castellano M, Fariello R, Montini E, Muiesan ML, Romanelli G, Muiesan G (1982) The acute and chronic hypotensive effect of labetalol and the relationship with pretreatment plasma noradrenaline levels. Br J Clin Pharmacol 13 (Suppl): 87S
Brittain RT, Levy GP (1976) A review of the animal pharmacology of AH 5158: a drug which blocks both alpha and beta adrenoceptors. Br J Clin Pharmacol 3 (Suppl): 681
Cerra FB, Siegel JH, Border JR, Peters DM, McMenamy RR (1979) Correlations between metabolic and cardiopulmonary measurements in patients after trauma, general surgery and sepsis. J Trauma 19:621
Cumming AMA, Brown JJ, Lever AF, Mackay A, Robertson JIS (1979) Treatment of severe hypertension by repeated bolus injection of labetalol. Br J Clin Pharmacol 8 (Suppl): 199S
Falkner B, Roven S, DeClement FA, Bendlin A (1978) Hypertension in children with burns. J Trauma 8:213
Farmer JB, Kennedy I, Levy GP, Marshall RJ (1972) Pharmacology of AH 5158: a drug which blocks both alpha and beta adrenoceptors. Br J Pharmacol 45:660
Hall-Matthews P (1979) Blood pressure changes in severely injured patients. Resuscitation 7:249
Jaatela A, Alpho A, Avikainen V, Karaharju E, Kataja J, Lahdensuu M, Lepisto P, Rokkanen P, Tervo T (1978) Plasma catecholamines in severely injured patients: a prospective study on 45 patients with multiple injuries. Br J Surg 62:177
Jackson SHD, Beevers DG (1983) Comparison of the effects of single doses of atenolol and labetalol on airways obstruction in patients with hypertension and asthma. Br J Clin Pharmacol 15:553
Larsson K (1982) Influence of labetalol, propranolol and practolol in patients with asthma. Eur J Respir Dis 63:221
Markley K, Smallman ET, Bruggs LW (1979) Early mortality and temperature regulation in burned mice following administration of catecholamines and adrenergic receptor blocking drugs. J Trauma 7:512
Martin LE, Hopkins R, Bland R (1976) Metabolism of labetalol by animals and man. Br J Clin Pharmacol 3 (Suppl):695
Pearson RM, Havard CWH (1976) Intravenous labetalol in hypertensive patients treated with beta-adrenoceptor blocking drugs. Br J Clin Pharmacol 3 (Suppl):795
Peter T, Norris RM, Clarke ED, Heng MK, Singh BN, Williams B, Howell DR, Ambler PK (1978) Reduction of enzyme levels by propranolol after acute myocardial infarction. Circulation 57:1091
Shalit MN, Cotew S (1974) Interrelationship between blood pressure and regional cerebral blood flow in experimental intracranial hypertension. J Neurosurg 40:594
Skinner C, Gaddie J, Palmer KNV (1975) Comparison of intravenous AH 5158 (Ibidomide) and propranolol in asthma. Br Med J 2:59
Wilmore DW, Long JM, Mason AD, Skreen RW, Pruitt BA (1974) Catecholamines: mediator of the hypermetabolic response to thermal injury. Ann Surg 180:653
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Morel, D.R., Forster, A. & Suter, P.M. Evaluation of I.V. labetalol for treatment of posttraumatic hyperdynamic state. Intensive Care Med 10, 133–137 (1984). https://doi.org/10.1007/BF00265802
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF00265802